Alto Neuroscience (Alto Neuroscience) Interest Expense : $-0.70 Mil (TTM As of Mar. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Alto Neuroscience Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Alto Neuroscience's interest expense for the three months ended in Mar. 2024 was $ -0.35 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.70 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Alto Neuroscience's Operating Income for the three months ended in Mar. 2024 was $ -14.39 Mil. Alto Neuroscience's Interest Expense for the three months ended in Mar. 2024 was $ -0.35 Mil. Alto Neuroscience did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alto Neuroscience Interest Expense Historical Data

The historical data trend for Alto Neuroscience's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alto Neuroscience Interest Expense Chart

Alto Neuroscience Annual Data

Trend

Dec21

Dec22

Dec23

Interest Expense

-1.37

Alto Neuroscience Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial			-	-0.32	-	-0.36	-0.35

Alto Neuroscience Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.70 Mil.

Alto Neuroscience (NYSE:ANRO) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Alto Neuroscience's Interest Expense for the three months ended in Mar. 2024 was $-0.35 Mil. Its Operating Income for the three months ended in Mar. 2024 was $-14.39 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was $8.81 Mil.

Alto Neuroscience's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Alto Neuroscience did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Alto Neuroscience (Alto Neuroscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alto Neuroscience Inc (NYSE:ANRO) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Alto Neuroscience Inc is a clinical stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individuals' neurobiology to develop personalized and highly effective treatment options. the company currently consists of five clinical-stage assets initially targeting major depressive disorder and schizophrenia populations as identified by independent brain-based biomarkers.

Alto Neuroscience (Alto Neuroscience) Headlines

From GuruFocus

Steven Cohen's Point72 Asset Management Buys New Stake in Alto Neuroscience Inc

By GuruFocus Research • 02-08-2024